UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predation of a pupfish by a fishing spider subsequently stolen by a diving beetle

The Southwestern naturalist, 2016-06, Vol.61 (2), p.135-137

2016

Volltextzugriff (PDF)

Neuroimaging of juvenile pilocytic astrocytomas: an enigma

Radiology, 1993-10, Vol.189 (1), p.221-225

1993

Volltextzugriff (PDF)

Peripheral benzodiazepine receptors and glucose metabolism in human gliomas

Journal of neuro-oncology, 1994-01, Vol.22 (1), p.15-22

1994

Volltextzugriff (PDF)

Effects of chronic diphenylhydantoin on cerebral metabolism in the adult rat

Experimental neurology, 1988-03, Vol.99 (3), p.523-530

1988

Volltextzugriff (PDF)

Differentation of pituitary adenoma and meningioma : visualization with positron emission tomography and [11C]-L-deprenyl

Neurosurgery, 1992, Vol.30 (6), p.855-861

1992

Volltextzugriff (PDF)

Ear preservation in the surgical treatment of auricular melanoma

Head & neck, 1990-07, Vol.12 (4), p.346-351

1990

Volltextzugriff (PDF)

A new way to monitor external ventricular drainage

Neurosurgery, 1992-04, Vol.30 (4), p.636-638

1992

Volltextzugriff (PDF)

TYPE I ODONTOID FRACTURES

Neurosurgery, 1989-09, Vol.25 (3), p.481

1989

Volltextzugriff (PDF)

Type I odontoid fractures

Neurosurgery, 1989-09, Vol.25 (3), p.481

1989

Volltextzugriff (PDF)

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

The lancet oncology, 2020-05, Vol.21 (5), p.671-684

2020

Volltextzugriff (PDF)

TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy

Drug resistance updates, 2017-11, Vol.33-35, p.36-42

2017

Volltextzugriff (PDF)

Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion

Blood, 2020-06, Vol.135 (23), p.2071-2084

2020

Volltextzugriff (PDF)

Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1

JNCI : Journal of the National Cancer Institute, 2011-08, Vol.103 (15), p.1190-1204

2011

Volltextzugriff (PDF)

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.829-840

2008

Volltextzugriff (PDF)

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Nature communications, 2018-12, Vol.9 (1), p.5193-13, Article 5193

2018

Volltextzugriff (PDF)

Type I odontoid fractures

Neurosurgery, 1989, Vol.25 (3), p.481-481

1989

Volltextzugriff (PDF)

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Future oncology (London, England), 2020-10, Vol.16 (30), p.2385-2399

2020

Volltextzugriff (PDF)

LBA63 A randomized phase I/II study of second line treatment with liposomal irinotecan and S-1 versus liposomal irinotecan and 5-fluorouracil in patients with metastatic pancreatic cancer following gemcitabine-based chemotherapy

Annals of oncology, 2024-09, Vol.35, p.S1252-S1252

2024

Volltextzugriff (PDF)

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation

Clinical cancer research, 2016-03, Vol.22 (6), p.1432-1444

2016

Volltextzugriff (PDF)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis

Oncotarget, 2015-05, Vol.6 (15), p.13822-13834

2015

Volltextzugriff (PDF)

324P Effect of NALIRIFOX in Asian patients (pts) with treatment-naive metastatic pancreatic adenocarcinoma (mPAC): Results from the NAPOLI 3 trial

Annals of oncology, 2024-06, Vol.35, p.S136-S137

2024

Volltextzugriff (PDF)

Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB

Molecular cancer research, 2009-05, Vol.7 (5), p.624-633

2009

Volltextzugriff (PDF)

Symptoms at diagnosis of (metastatic) pancreatic adenocarcinoma ([m]PAC) in routine practice and frequency variation across Europe

Annals of oncology, 2018-11, Vol.29, p.ix61-ix62

2018

Volltextzugriff (PDF)

First-line (1L) full dose (f) and modified (m) FOLFIRINOX and gemcitabine+nab-paclitaxel (GN) treatment (tx) for metastatic pancreatic adenocarcinoma (mPAC) patients (pts) in routine clinical practice across Europe

Annals of oncology, 2018-10, Vol.29, p.viii244-viii245

2018

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(58)
Berichte
(1)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(21)
Clinical Cancer Research
(5)
Journal Of Clinical Oncology
(5)
Neurosurgery
(4)
Cancer Research
(2)
Expert Opinion On Therapeutic Targets
(2)
Molecular Cancer Research
(2)
Blood
(1)
Drug Resistance Updates
(1)
Esmo Open
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Predation of a pupfish by a fishing spider subsequently stolen by a diving beetle

Neuroimaging of juvenile pilocytic astrocytomas: an enigma

Peripheral benzodiazepine receptors and glucose metabolism in human gliomas

Effects of chronic diphenylhydantoin on cerebral metabolism in the adult rat

Differentation of pituitary adenoma and meningioma : visualization with positron emission tomography and [11C]-L-deprenyl

Ear preservation in the surgical treatment of auricular melanoma

A new way to monitor external ventricular drainage

TYPE I ODONTOID FRACTURES

Type I odontoid fractures

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy

Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion

Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Type I odontoid fractures

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

LBA63 A randomized phase I/II study of second line treatment with liposomal irinotecan and S-1 versus liposomal irinotecan and 5-fluorouracil in patients with metastatic pancreatic cancer following gemcitabine-based chemotherapy

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis

324P Effect of NALIRIFOX in Asian patients (pts) with treatment-naive metastatic pancreatic adenocarcinoma (mPAC): Results from the NAPOLI 3 trial

Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB

Symptoms at diagnosis of (metastatic) pancreatic adenocarcinoma ([m]PAC) in routine practice and frequency variation across Europe

First-line (1L) full dose (f) and modified (m) FOLFIRINOX and gemcitabine+nab-paclitaxel (GN) treatment (tx) for metastatic pancreatic adenocarcinoma (mPAC) patients (pts) in routine clinical practice across Europe

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer

Suchergebnisse filtern